Cellectis Net Income Applicable To Common Shares from 2010 to 2026
| ALCLS Stock | EUR 3.38 0.19 5.96% |
Net Loss | First Reported 2012-12-31 | Previous Quarter -17.1 M | Current Value -18.1 M | Quarterly Volatility 13.1 M |
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Interest Expense of 9 M, Selling General Administrative of 25 M or Total Revenue of 25.1 M, as well as many indicators such as Price To Sales Ratio of 3.12, Dividend Yield of 0.0 or PTB Ratio of 1.26. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
Cellectis | Net Income Applicable To Common Shares |
Evaluating Cellectis's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Cellectis's fundamental strength.
Latest Cellectis' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Cellectis over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Cellectis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Cellectis Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (61,205,179) | |
| Coefficient Of Variation | (60.32) | |
| Mean Deviation | 30,615,831 | |
| Median | (55,402,000) | |
| Standard Deviation | 36,920,677 | |
| Sample Variance | 1363.1T | |
| Range | 117M | |
| R-Value | (0.33) | |
| Mean Square Error | 1297.2T | |
| R-Squared | 0.11 | |
| Significance | 0.20 | |
| Slope | (2,401,187) | |
| Total Sum of Squares | 21810.2T |
Cellectis Net Income Applicable To Common Shares History
About Cellectis Financial Statements
Cellectis shareholders use historical fundamental indicators, such as Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -33.1 M | -34.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.